US Stocks
FNCH
Finch Therapeutics Group, Inc. Common Stock
$7.30
+0.00 (+0.00%)
Volume:
0 ($0.00)
Market Capitalization:
-
Finch Therapeutics Group Price Chart
*There is no price data available for this ticker
Finch Therapeutics Group Volume Chart
*There is no volume data available for this ticker
Finch Therapeutics Group Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
*No Trades in Segment
Premarket Yesterday
*No Trades in Segment
Finch Therapeutics Group News
There is no current news for this stock at the moment.
Finch Therapeutics Group Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Finch Therapeutics Group Moving Averages
| 5 Day Moving Average (SMA5) | $11.49 |
|---|---|
| 10 Day Moving Average (SMA10) | $12.25 |
| 20 Day Moving Average (SMA20) | $12.78 |
| 50 Day Moving Average (SMA50) | $13.35 |
| 100 Day Moving Average (SMA100) | $13.19 |
| 200 Day Moving Average (SMA200) | $13.16 |
Finch Therapeutics Group Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Finch Therapeutics Group Stock Splits
There has been 1 stock split for Finch Therapeutics Group (FNCH). The reverse stock split occured on June 12, 2023 and reduced the outstanding shares at a ratio of 30:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 12, 2023 | Reverse | 30:1 |
Finch Therapeutics Group Dividends
There have been no dividends for Finch Therapeutics Group (FNCH).